ScienceDex / Researcher record
Acharya, Suchismita
- Ayuvis Research, Inc. (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $273,826 | 1 | #28,243 |
| 2020 | $365,000 | 1 | #15,413 |
| 2021 | $505,758 | 2 | #21,499 |
| 2022 | $1,468,034 | 2 | #5,839 |
| 2023 | $1,546,851 | 4 | #5,549 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2017 · selected1 record
- FY20201 record
- FY20212 records
- FY20222 records
- FY20234 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Acharya, Suchismita as a PI. Multi-PI records show the full award amount for context.
- 1R43AI129164-01R43Contact PINovel multifunctional oligosaccharide for treating sepsis and severe sepsis.$273.8Kaward amount
Award organization
Organizations that administered FY2017 awards listing Acharya, Suchismita as a PI.
FY2017 award administered by Ayuvis Research, Inc. (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardAyuvis Research, Inc.
- 2020$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5839